Výsledky vyhledávání

Akademický článek

Specific anti-IIa activity is a key indicator of safety and efficacy in validation of biosimilarity of unfractioned heparin preparations.

Autor: Mironov AN; Research Center for Evaluation of Medical Products, the Ministry of Health of the Russian Federation, Moscow, Russia., Goryachev DV, Garvishina EV, Niyazov RR, Ivanova OY

Publikováno v: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2015 Feb; Vol. 158 (4), pp. 450-2. Date of Electronic Publication: 2015 Feb 24.

Zobrazit plný text záznamu

Akademický článek

[GOOD PLANNING PRACTICE IN PRECLINICAL AND CLINICAL STUDIES OF UNFRACTIONATED AND FRACTIONATED HEPARINS IN RUSSIA AS THE BASIS OF SAFE AND EFFECTIVE ANTICOAGULATION THERAPY].

Autor: Gavrishina EV, Dobrovolskii AV, Niyazov RR, Romodanovskii DP, Vasil'ev AN

Publikováno v: Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2015; Vol. 78 (11), pp. 15-20.

Zobrazit plný text záznamu

Akademický článek

[PLANNING THE DESIGN AND ESTIMATING THE RESULTS OF INVESTIGATIONS OF BIOEQUIVALENCE OF HIGHLY VARIABLE DRUGS BY EXAMPLE OF ROSUVASTATIN].

Autor: Romodanovskii DP, Dranitsyna MA, Goryachev DV, Niyazov RR, Gavrishina EV

Publikováno v: Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2015; Vol. 78 (6), pp. 19-25.

Zobrazit plný text záznamu

Akademický článek

[JUSTIFICATION OF USING EQUIVALENCE OF THE INDICES OF QUALITY, SAFETY, AND EFFICACY IN DEVELOPING BIOANALOGS].

Autor: Niyazov RR, Goryachev DV, Gavrishina EV, Romodanovskii DP, Dranitsyna MA

Publikováno v: Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2015; Vol. 78 (6), pp. 37-44.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání